HIV prevention efforts expand in Mozambique and Ghana via PrEP

Health authorities in Mozambique and Ghana are highlighting the availability and uptake of Pre-Exposure Prophylaxis (PrEP) as a key component of their HIV prevention strategies.

In Maputo, Mozambique, health officials report high uptake of the long-acting injectable lenacapavir across 27 health facilities. Since its rollout in May, the injectable method has been favored by many patients because it requires only two doses per year, reducing the frequency of clinic visits. The implementation focuses on vulnerable groups, including adolescents, pregnant women, and key populations.

In Ghana, the Ghana AIDS Commission is promoting the use of PrEP in tablet form for individuals at higher risk of HIV exposure. While injectable formulations exist, the current availability in Ghana is limited to oral tablets. Officials emphasize that PrEP is a preventive tool for HIV-negative individuals and should be used alongside other prevention measures. The commission encourages those in high-risk groups, such as sex workers and men who have sex with men, to seek professional medical advice regarding the medication.